GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
86 hedge funds and large institutions have $61.6M invested in G1 Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
-1
Holders Change %
-1.15%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
31
Reduced
17
Closed
19
Calls
$4.23M
Puts
$1.76M
Net Calls
+$2.47M
Net Calls Change
+$1.25M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$1.94M |
| 2 |
2
Millennium Management
New York
|
$1.93M |
| 3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$1.87M |
| 4 |
4
D.E. Shaw & Co
New York
|
$3.39M |
| 5 |
5
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$1.4M |
